As Bluebird’s CAR-T Competition Intensifies, Sickle Cell Therapy Brings Upside
Early Data Suggests Superiority Against Pain Crises
The growth of blood cancer pipelines, as well as other hematological disorders, has made ASH a key congress • Source: ASH 
